Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Amjevita

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Amgevita

    02 3Hadlima

    03 19Humira

    04 7Imraldi

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    Abbvie

    Adalimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 19,832

    2019 Revenue in Millions : 19,169

    Growth (%) : 3

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    Abbvie

    Adalimumab

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2017 Revenue in Millions : 18,427

    2016 Revenue in Millions : 16,078

    Growth (%) : 15

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    AbbVie

    Adalimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 20,694

    2020 Revenue in Millions : 19,832

    Growth (%) : 4

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    Abbvie

    Adalimumab

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2016 Revenue in Millions : 16,078

    2015 Revenue in Millions : 14,012

    Growth (%) : 15

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    AbbVie

    Adalimumab

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2015 Revenue in Millions : 12,543

    2014 Revenue in Millions : 14,012

    Growth (%) : 12%

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    AbbVie

    Adalimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 21,237

    2021 Revenue in Millions : 20,694

    Growth (%) : 3

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    AbbVie

    Adalimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 14,404

    2022 Revenue in Millions : 21,237

    Growth (%) : -32

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    AbbVie

    Adalimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2024 Revenue in Millions : 8,993

    2023 Revenue in Millions : 14,404

    Growth (%) : -38

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    Abbvie

    Adalimumab

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2018 Revenue in Millions : 19,936

    2017 Revenue in Millions : 18,427

    Growth (%) : 8%

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Humira

    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed

    AbbVie

    Adalimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2019 Revenue in Millions : 19,169

    2018 Revenue in Millions : 19,936

    Growth (%) : -4

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.